Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-14T21:22:31.180Z Has data issue: false hasContentIssue false

Chapter 13 - The business of biotechnology

Published online by Cambridge University Press:  05 June 2012

Jason Rushton
Affiliation:
Merlin Biosciences Ltd, UK
Christopher Evans
Affiliation:
Merlin Biosciences Ltd, UK
Colin Ratledge
Affiliation:
University of Hull
Bjorn Kristiansen
Affiliation:
EU Biotech Consulting, Norway
Get access

Summary

Introduction

Biotechnology is the exploitation of biological processes for industrial or other purposes. In this chapter we will discuss the biotechnology industry's development from its initial manifestation – the biotech start-up company through its maturation and development to yield integrated companies contributing products on a global scale – and what factors contribute to the success and failure of the entrepreneurial application of the science described elsewhere in this volume. This industry appeared in the 1970s, initially in the USA (an opportunity created by intellectual resource and inherent entrepreneurial spirit allied to a powerful capitalist environment) and soon afterwards in Europe and Asia as well. Our aim in this chapter is to give you a feel for what you need to have, and what you need to do, if you are to start up and successfully run a biotechnology company.

What is biotechnology used for?

As an introduction, we will review what companies are using biotechnology for, to see why some areas have been successful and others have failed.

The applications: medicine

The significant proportion of biotechnology investment has been directed to health-care, and specifically in the discovery of new drugs. Patents provide legal protection and mean that an effective new drug can be sold at high price for as long as the patent on it prevents someone else from making and selling it at a lower price. Once a drug comes off patent it can be manufactured as a generic, and sales and profit margins for the originator rapidly plummet.

Type
Chapter
Information
Basic Biotechnology , pp. 307 - 334
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×